GlassScriptPhysician profile
Roudette Ferrer
NPI 1063918985
$3,370.36
in general payments reported to CMS, 2019-2025
18 companies · $379 in 2025
The $379 reported for 2025 was more than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $456 · 2022: $1,014 · 2023: $776 · 2024: $744 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $602.98 | 2024-2025 | Spravato |
| Abbvie INC. | $602.74 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $250.18 | 2022-2024 | Farxiga |
| Si-Bone, INC. | $246.43 | 2021-2022 | |
| Novo Nordisk INC | $201.96 | 2022 | |
| Genzyme Corporation | $149.92 | 2023 | |
| Esperion Therapeutics, INC. | $125.00 | 2021 | |
| Inari Medical, INC. | $125.00 | 2022 | |
| Dexcom, INC. | $124.99 | 2022 | |
| Xeris Pharmaceuticals, INC. | $124.99 | 2023 | Gvoke Hypopen |
| Astellas Pharma US INC | $124.28 | 2023 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $122.07 | 2022 | |
| Abbott Laboratories | $120.06 | 2023 | Freestyle Libre 3 |
| Neurocrine Biosciences, INC. | $114.08 | 2023 | |
| Teva Pharmaceuticals USA, INC. | $109.82 | 2025 | Uzedy |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $105.60 | 2021 | |
| Lucid Diagnostics INC. | $102.14 | 2022 | |
| Lilly USA, LLC | $18.12 | 2023 | Jardiance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roudette Ferrer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.